<DOC>
	<DOCNO>NCT01108146</DOCNO>
	<brief_summary>To test overall efficacy hydrocortisone reexperience traumatic memory ( intrusion ) overall symptomatology patient meet criterion complex chronic PTSD .</brief_summary>
	<brief_title>Hydrocortisone Treatment Intrusions Patients With Posttraumatic Stress Disorder</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Stress Disorders , Traumatic</mesh_term>
	<mesh_term>Stress Disorders , Post-Traumatic</mesh_term>
	<mesh_term>Polystyrene sulfonic acid</mesh_term>
	<mesh_term>Hydrocortisone 17-butyrate 21-propionate</mesh_term>
	<mesh_term>Cortisol succinate</mesh_term>
	<mesh_term>Hydrocortisone acetate</mesh_term>
	<mesh_term>Hydrocortisone</mesh_term>
	<criteria>Written Informed Consent Female patient PTSD accord DSMIV criterion ( see Appendix 2 ) . 1845 year Intrusions ( accord IESR subscale Intrusions : Value : &gt; 7 Ability subject understand character individual consequence clinical trial No participation another clinical trial ( 30 day trial ) Lifetime diagnosis schizophrenia accord DSMIV Mental retardation Body mass index &lt; 16.5 Current drug alcohol abuse addiction Lifethreatening selfinjurious behavior last 4 month Suicide attempt strong intention die last 4 month . Following disease anamnesis : stomach ulcera intestinal ulcera , pancreatitis , corticoidinduced psychosis , severe osteoporosis , severe hypertension , heart failure , myasthenia gravis , asthma bronchiale , glaucoma , cataract , diabetes mellitus , herpes simple , herpes zoster ( viremic phase ) , renal transplantation . Any pretreatment hydrocortisone last 4 week prior first administration Investigational Medicinal Product . Following current medication : cardiac glycoside , saluretics , antidiabetic , cumarinderivatives , rifampicine , phenytoine , barbiturate , primidone , NSAID , salicylate indometacine , atropine , praziquantel , chloroquine , hydroxychloroquine , mefloquine , somatropine , protireline , cyclosporine , nondepolarising muscle relaxant . Pregnancy lactation period Inadequate birth control ( Adequate birth control : implant , injectables , combine oral contraceptive , intrauterine device ( IUDs ) , sexual abstinence vasectomise partner ) Shift work Intercontinental travel within 2 week prior enrollment ( avoid jetlag ) History hypersensitivity investigational medicinal product drug similar chemical structure excipient present pharmaceutical form investigational medicinal product . No subject allow enrol trial .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>January 2013</verification_date>
</DOC>